⚡Stay ahead in research with Novelty Scores – comparing 250M+ articles to flag game-changing studies. Spot breakthroughs faster in cancer, cardiovascular health & beyond.

Discover how: shorturl.at/ilvaD
#ResearchInnovation #NoveltyScores

Spot groundbreaking research before it hits the headlines.

Our novelty scores help you find the most innovative studies across 50M+ articles—fast.

Stay ahead of the curve 👉 shorturl.at/ilvaD
#ResearchInnovation #NoveltyScores

🚨 Want to spot game-changing science before it trends?

🧠 Our novelty scores rank 50M+ papers by originality — so you find what’s truly new.

🔬 For researchers, investors, and the curious.

🚀 Start exploring: shorturl.at/ilvaD
#DeSci #NoveltyScores

By comparing 250 million articles, we help pharma, researchers and investors find impactful studies on diseases like cancer and cardiovascular conditions.
This saves time and unlock new opportunities.
Explore now: shorturl.at/ilvaD

#DeSciLabs #PharmaInnovation #NoveltyScores #OpenScience

DeSci Labs now offers free novelty scores for all users on DeSci Publish!
Instantly assess how unique your research is with content and context novelty scores, helping boost your journal submissions and funding applications.

shorturl.at/ilvaD

#DeSciLabs #OpenScience #NoveltyScores

Find groundbreaking research before it’s published!
🔎Search 250M+ articles by field, institution, or journal using novelty scores to spot the most innovative work.
Stay ahead - shorturl.at/ilvaD
#ResearchInnovation #NoveltyScores #FutureOfScience

Novelty scores available for all for first time DeSci Publish users receive content and context novelty scores for their uploaded manuscripts

Sign in to DeSci Publish today, and upload your manuscript to get your novelty score, now available to all users!

Use your score to boost your grant application and publication chances.

Interested? Join today and get 100GB of free storage!

#SciencePublishing #NoveltyScores #GrantFunding

Q&A: How novelty scores can affect pharma Philipp Koellinger, co-founder and CEO DeSci Labs, explains what novelty scores are, and the effect they can have on the pharmaceutical sector.

DeSci Labs CEO Philipp Koellinger explains how novelty scores are revolutionizing #pharma by pinpointing innovative studies.

By analyzing keyword and citation combinations, they highlight key research areas, boosting insights for cancer and cardiovascular diseases.

#NoveltyScores #OpenScience